logo

SCIENCE CHINA Life Sciences, Volume 57 , Issue 2 : 195-200(2014) https://doi.org/10.1007/s11427-013-4605-y

Timing of transplantation of autologous bone marrow derived mesenchymal stem cells for treating myocardial infarction

More info
  • AcceptedOct 2, 2013
  • PublishedJan 25, 2014

Abstract


References

[1] Strauer BE, Brehm M, Zeus T, Gattermann N, Hernandez A, Sorg RV, Kögler G, Wernet P. Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction. Dtsch Med Wochenschr, 2001, 126: 932-938. Google Scholar

[2] Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation, 2002, 106:1913-1918. Google Scholar

[3] Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation, 2002, 105: 93-98. Google Scholar

[4] Tambara K, Sakakibara Y, Sakaguchi G, Lu F, Premaratne GU, Lin X, Nishimura K, Komeda M. Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers. Circulation, 2003, 108(Suppl 1): II259-263. Google Scholar

[5] Yu YS, Shen ZY, Ye WX, et al. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium. Chin Med J (Engl), 2010, 123: 1702-1708. Google Scholar

[6] Wakitani S, Saito T, Caplan AI. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve, 1995, 18: 1417-1426. Google Scholar

[7] Frangogiannis NG, Mendoza LH, Lewallen M, Michael LH, Smith CW, Entman ML. Induction and suppression of interferon-inducible protein 10 in reperfused myocardial infarcts may regulate angiogenesis. FASEB J, 2001, 15: 1428-1430. Google Scholar

[8] Kofidis T, de Bruin JL, Yamane T, Tanaka M, Lebl DR, Swijnenburg RJ, Weissman IL, Robbins RC. Stimulation of paracrine pathways with growth factors enhances embryonic stem cell engraftment and host specific differentiation in the heart after ischemic myocardial injury. Circulation, 2005, 111: 2486-2493. Google Scholar

[9] Li RK, Mickle DA, Weisel RD, Rao V, Jia ZQ. Optimal time for cardiomyocyte transplantation to maximize myocardial function after left ventricular injury. Ann Thorac Surg, 2001, 72: 1957-1963. Google Scholar

[10] Schenk S, Mal N, Finan A, Zhang M, Kiedrowski M, Popovic Z, McCarthy PM, Penn MS. Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells, 2007, 25: 245-251. Google Scholar

[11] Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol, 2007, 8: 49-62. Google Scholar

[12] Bonello S, Zähringer C, BelAiba RS, Djordjevic T, Hess J, Michiels C, Kietzmann T, Görlach A. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler Thromb Vasc Biol, 2007, 27: 755-761. Google Scholar

[13] Sarkar A, Sreenivasan Y, Ramesh GT, Manna SK. beta-D-Glucoside suppresses tumor necrosis factor-induced activation of nuclear transcription factor kappaB but potentiates apoptosis. J Biol Chem, 2004, 279: 33768-33781. Google Scholar

[14] Dechend R, Fiebeler A, Park JK, Muller DN, Theuer J, Mervaala E, Bieringer M, Gulba D, Dietz R, Luft FC, Haller H. Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglu- taryl coenzyme a reductase inhibitor. Circulation, 2001, 104: 576-581. Google Scholar

[15] Hamano K, Nishida M, Hirata K, Mikamo A, Li TS, Harada M, Miura T, Matsuzaki M, Esato K. Local implantation of autologous bone marrow cell for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results. Jpn Circ J, 2001, 65: 845-847. Google Scholar

[16] Suárez de Lezo J, Herrera C, Romero MA, Pan M, Jiménez R, Carmona D, Segura JM, Nogueras S, Mesa D, Suárez de Lezo J, Pavlovic D, Ojeda S, Torres A. Functional recovery following intracoronary infusion of autologous mononuclear bone marrow cells in patients with chronic anterior myocardial infarction and severely depressed ventricular function. Rev Esp Cardiol, 2010, 63: 1127-1135. Google Scholar

[17] Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. J Clin Invest, 1991, 87: 1402-1412. Google Scholar

[18] Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, Fichtner S, Hecker H, Schaefer A, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation, 2006, 14, 113: 1287-1294. Google Scholar

qqqq

Contact and support